6.00Open6.00Pre Close0 Volume106 Open Interest12.50Strike Price0.00Turnover181.34%IV12.26%PremiumDec 20, 2024Expiry Date3.98Intrinsic Value100Multiplier27DDays to Expiry2.02Extrinsic Value100Contract SizeAmericanOptions Type0.7923Delta0.0353Gamma3.14Leverage Ratio-0.0445Theta0.0057Rho2.49Eff Leverage0.0128Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet